A familial defect of T-cell receptor (TCR)/CD3 complex expression by T lymphocytes, due to a selective deficiency of the CD3γ subunit, was reported in 1986.1,2 Two brothers (V and D) had inherited mutations in both the paternal and maternal CD3γ genes that severely truncated the protein.3 V had very low counts of peripheral blood CD3+ cells and a low density of TCR/CD3 molecules per cell and a severe combined immunodeficiency and autoimmune enteropathy with gut epithelial cell autoantibodies (GECA, cytoplasm 1/16, and brush border greater than 1/64). He died at 32 months of age after severe infections and autoimmunity. Still-living sibling D shared the same genotype regarding CD3γ but had milder laboratory immunological and clinical parameters.4 

D was born in 1981 and began showing clinical symptoms at 12 months of age, including infrequent episodes of repeated Gram-positive and -negative bacterial infections (easily controlled), asthma, diarrhea (which spontaneously disappeared after 6 years), vitiligo, and atopic eczema. A lymphocytary meningitis of probable viral origin (which was quickly overcome) and a mild dilated cardiomyopathy (DCM; probably secondary to unrecorded viral infections) with slight valvular insufficiency were diagnosed at the age of 11 years. Otherwise, D has had a normal development and life (including playing frequent short football matches) and is currently 18 years old.

Table 1 summarizes D's most relevant immunological parameters since 1995. Mean CD3+ cells percentage remains approximately 20% lower in D (ranging from 44% to 57%) than in normal controls (ranging from 60% to 80%), and the surface density of CD3 molecules per cell is 4 times lower in D than in normal controls. Serum autoantibodies were never found before June 1999, when antityroglobulin (185 IU/mL; normal range, 0-89 IU/mL) and antithyroid peroxidase autoantibodies (251 IU/mL; normal range, 0-41 IU/mL) appeared. They were also positive in January 2000 and have been maintained so until this writing.5 Thyroid hormones (T4, free T4, and TSH) are normal,6 and thyroid clinical symptoms are absent. Several D alterations (vitiligo, DCM, specific thyroid autoantibodies) may certainly have an organ-specific autoimmune etiopathogeny.7 These autoimmune anomalies may be directly related to the CD8 cytotoxic/suppressor−CD4 lymphocyte disbalance and to the persistent high numbers of memory T-cell clones (CD4+CD45R0+) (Table 1). Autoantibodies against GECA, intrinsic factor, insulin, gliadin, kidney glomerular membrane, islet cell, antinuclear, double-stranded DNA, RNP, SSb, Sm, Ro, Scl-70, mitochondrial, smooth muscle, epithelial basement membrane, centromere, parietal cell, intercellular substance, striated muscle, and adrenal antibodies have been repeatedly negative.5 8 

Table 1.

Major immunological data since 1995

Dec 1995Nov 1996Feb 1997Mar 1998Feb 1999Jan 2000
Lymphocytes* 1100 838 970 1014 1090 1215 
CD cells       
 CD4 47  (39-56) 42  (36-56) 48  (36-56) 44  (36-56) 47  (36-56) 50  (36-56) 
 CD4+CD45R0+ 41  (15-29) 39  (10-27) 47  (10-27) 42  (10-27) 40  (10-27) 47  (10-27) 
 CD4+CD45RA+ 3  (13-35) 6  (10-35) 3  (10-35) 3  (10-35) 3  (10-35) 3  (10-35) 
 CD8 9  (15-27) 5  (13-31) 9  (13-31) 7  (13-31) 4  (13-31) 7  (13-31) 
Total immunoglobulin 
 IgG 609  (697-1593) — 594  (697-1593) 609  (697-1593) 671  (644-1436) 688  (644-1436) 
 IgG2 90  (140-440) — 147  (95-468) 142  (95-468) 148  (95-468) 146  (95-468) 
 IgM 39  (39-330) — 37  (39-330) 38  (39-330) 39  (55-206) 40  (55-206) 
Dec 1995Nov 1996Feb 1997Mar 1998Feb 1999Jan 2000
Lymphocytes* 1100 838 970 1014 1090 1215 
CD cells       
 CD4 47  (39-56) 42  (36-56) 48  (36-56) 44  (36-56) 47  (36-56) 50  (36-56) 
 CD4+CD45R0+ 41  (15-29) 39  (10-27) 47  (10-27) 42  (10-27) 40  (10-27) 47  (10-27) 
 CD4+CD45RA+ 3  (13-35) 6  (10-35) 3  (10-35) 3  (10-35) 3  (10-35) 3  (10-35) 
 CD8 9  (15-27) 5  (13-31) 9  (13-31) 7  (13-31) 4  (13-31) 7  (13-31) 
Total immunoglobulin 
 IgG 609  (697-1593) — 594  (697-1593) 609  (697-1593) 671  (644-1436) 688  (644-1436) 
 IgG2 90  (140-440) — 147  (95-468) 142  (95-468) 148  (95-468) 146  (95-468) 
 IgM 39  (39-330) — 37  (39-330) 38  (39-330) 39  (55-206) 40  (55-206) 

Previous data have been published elsewhere.9Phenotype and T-cell activation results (using mitogens and antigens) are at present similar to those reported before.9 —indicates data not determined.

*

Lymphocytes are expressed in number per microliter.

Each CD cell entry is expressed in percentage of positive cells (range of normal values for aged-matched controls in brackets). A severe decrease in the number and function of CD4+CD45RA+ and cytotoxic (CD8+) lymphocytes is maintained, whereas CD4+CD45R0+, B, and NK lymphocytes are unaffected.9 These data allow us to propose a model where CD4 or CD8 molecules interact with the TCR/CD3 complex during antigen recognition through the CD3δ or the CD3γ protein of the complex, respectively.3 This also correlates with previously obtained data suggesting that αβδεζ complexes are biochemically stable (albeit epitopically altered) and may reach the cell surface in certain circumstances.4 

Immunoglobulins expressed in mg/dL (range of normal values for aged-matched controls in brackets). IgG1, IgG3, IgG4, and IgA levels are always into normal ranges.

Previous studies showed that the γ chain is the CD3 component that interacts with the αβ TCR heterodimer. But our data support that a CD3 chain other than γ may also associate to αβ (ie, the highly homologous δ).4 This could explain D's relatively mild clinical course and cellular phenotype (Table 1). Also, redundant and overlapping functions among proteins of the immune system permit the existence of healthy but immunodeficient individuals, the best known being congenital C2, IgA, HLA class I, and adenosine deaminase deficiencies. Immune function is apparently sufficient for the survival of the CD3γ-lacking D patient, but continuing a close follow-up will enable us to determine the real importance of adaptive versus nonadaptive immune mechanisms throughout an individual's life and to study the mechanisms that relate autoimmunity and immunodeficiency.

Supported by grants from the Ministerio de Educación (PM95-57 and PM96-21) and Comunidad de Madrid (06/70/97 and 8.3/14/98).

1
Regueiro
JR
Arnaiz-Villena
A
Ortiz de Landázuri
M
et al
Familial defect of CD3 (T3) expression by T cells associated with rare gut epithelial cell autoantibodies.
Lancet.
1
1986
1274
1275
2
Alarcón
B
Regueiro
JR
Arnaiz-Villena
A
Terhorst
C
Familial defect in the surface expression of the T-cell receptor-CD3 complex.
N Engl J Med.
319
1988
1203
1208
3
Arnaiz-Villena
A
Timón
M
Corell
A
Pérez-Aciego
P
Martı́n-Villa
JM
Regueiro
JR
Primary immunodeficiency caused by mutations in the gene encoding the CD3-γ subunit of the T-lymphocyte receptor.
N Engl J Med.
327
1992
529
533
4
Alarcón
B
Terhorst
C
Arnaiz-Villena
A
Pérez-Aciego
P
Regueiro
JR
Congenital T-cell receptor immunodeficiencies in man.
Immunodeficiency Rev.
2
1990
1
16
5
Rose
NR
Friedman
H
Fahey
JL
Manual of Clinical Laboratory Immunology. Third ed.
1986
American Society for Microbiology
Washington, DC
6
Wiedemann
G
Jonetz-Mentzel
L
Panse
R
Establishment of reference ranges for thyrotropin, triiodothyronine, thyroxine and free thyroxine in neonates, infants, children and adolescents.
Eur J Clin Chem Clin Biochem.
31
1993
277
278
7
Stites
DP
Terr
AI
Parslow
TG
Basic and Clinical Immunology.
1994
Appleton and Lange
Connecticut
8
Martı́n-Villa
JM
Regueiro
JR
de Juan
D
et al
T-lymphocyte dysfunctions occurring together with apical gut epithelial cell autoantibodies.
Gastroenterol.
101
1991
390
397
9
Timón
M
Arnaiz-Villena
A
Rodrı́guez-Gallego
C
Pérez-Aciego
P
Pacheco
A
Regueiro
JR
Selective disbalances of peripheral blood T lymphocyte subsets in human CD3γ deficiency.
Eur J Immunol.
23
1993
1440
1444
Sign in via your Institution